Vaccitech

NASDAQ: VACC · Real-Time Price · USD
5.00
0.51 (11.36%)
At close: Nov 06, 2023, 10:00 PM

Vaccitech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
86.26M 99.12M 110.66M 106.1M 117.77M 160.31M 173.03M 191.33M 194.38M 200.1M 192.33M 200.6M 214.05M 233.87M 243.62M 155.94M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
944K 902K 881K 926K 886K 1.05M 1.01M 1.03M 976K 847K 902K 788K 804K 719K n/a n/a
Receivables
n/a n/a n/a n/a n/a 10.4M 349K 172K 323K 26K 17.05M 18.01M 20K 42K 37K 312K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a 5.89M 7.9M 9.94M 5.48M 5.47M 5.64M 7.51M n/a
Other Current Assets
14.15M 10.76M 15.08M 28.55M 14.11M 10.76M 11.4M 9.16M 18.33M 18.49M 16.92M 12.18M 12.69M 12.07M 13.07M 7.12M
Total Current Assets
100.41M 109.88M 125.74M 134.65M 131.88M 171.06M 184.78M 200.66M 213.04M 218.62M 226.29M 230.78M 226.76M 245.98M 256.73M 163.37M
Property-Plant & Equipment
7.84M 10.06M 11.76M 18.16M 18.25M 19.74M 21.45M 20.43M 15.71M 14.32M 15.38M 11.28M 9.09M 9.81M 3.08M 3.1M
Goodwill & Intangibles
20.37M 21.16M 21.95M 34.95M 35.74M 38.11M 38.9M 39.69M 40.48M 41.69M 42.48M 43.27M 44.06M n/a n/a n/a
Total Long-Term Assets
29.15M 32.11M 34.59M 54.03M 54.87M 58.91M 61.35M 61.15M 57.16M 56.86M 58.77M 55.34M 53.95M 10.59M 3.11M 3.13M
Total Assets
129.56M 142M 160.33M 188.69M 186.75M 229.97M 246.13M 261.82M 270.2M 275.48M 285.06M 286.12M 280.71M 256.57M 259.84M 166.49M
Account Payables
1.8M 1.36M 2.47M 3.08M 2.56M 5.14M 2.43M 4.33M 3.75M 2.41M 4.47M 4.66M 2.42M 1.34M 4.68M 4.83M
Deferred Revenue
1.52M 1.46M 1.74M 2.04M 839K n/a n/a n/a n/a 111K 136K 162K 182K 196K 217K 346K
Short-Term Debt
2.04M 1.96M 1.92M 1.99M 1.92M 1.5M 1.14M 649K 433K 186K 299K 331K 682K 435K 202K 198K
Other Current Liabilities
9.16M 8.55M 12M 11.04M 10.28M 11.92M 8.55M 7.01M 8.06M 11.32M 7.26M 11.33M 7.88M 4.4M 3.44M 3.27M
Total Current Liabilities
12.72M 11.98M 15.66M 15.07M 15.59M 18.57M 12.11M 11.99M 12.24M 14.03M 12.17M 16.48M 11.16M 6.37M 8.54M 8.65M
Long-Term Debt
9.95M 9.96M 10.09M 10.68M 10.65M 11.2M 11.04M 10.01M 8.34M 8.07M 8.31M 6.4M 6.54M 7.73M 1.38M 1.44M
Other Long-Term Liabilities
4.01M 4.05M 4.01M 3.02M 3.23M 3.08M 3.42M 3.02M 2.68M 3.55M 3.5M 2.88M 2.37M n/a n/a 209.24M
Total Long-Term Liabilities
14.36M 14.43M 14.54M 14.16M 14.37M 15.8M 16.55M 16.26M 14.76M 17.3M 18.12M 16.5M 17M 7.73M 1.38M 210.67M
Total Liabilities
27.08M 26.4M 30.19M 29.23M 29.96M 34.37M 28.67M 28.25M 27M 31.33M 30.29M 32.99M 28.15M 14.1M 9.93M 219.32M
Total Debt
11.99M 11.92M 12.01M 12.67M 12.57M 12.7M 12.18M 10.65M 8.77M 8.26M 8.61M 6.74M 7.22M 8.16M 1.59M 1.63M
Common Stock
1K 1K 1K 1K 1K 1K 1K 1K 1K 1K 1K 1K 1K 1K 1K n/a
Retained Earnings
-278.44M -257.31M -237.66M -217.12M -209.01M -159.3M -145.22M -121.42M -103.24M -82.05M -90.3M -105.99M -108.58M -93.47M -88.92M -72.99M
Comprehensive Income
-12.94M -21.23M -25.87M -15.55M -24.73M -31.1M -23.29M -28.89M -33.46M -51.14M -31.23M -14.46M -8.49M -9.04M -2.58M -2.66M
Shareholders Equity
102.38M 115.49M 130.03M 159.29M 156.62M 195.4M 217.21M 233.3M 242.9M 243.84M 254.4M 252.74M 252.13M 241.98M 249.39M -53.11M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a